# Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions

> **NCT05877131** · PHASE4 · UNKNOWN · sponsor: **Althaia Xarxa Assistencial Universitària de Manresa** · enrollment: 40 (estimated)

## Conditions studied

- Hemodynamic Instability
- Epidural
- Pregnancy
- Fetal Cardiac Disorder

## Interventions

- **DRUG:** Levobupivacaine
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT05877131
- **Lead sponsor:** Althaia Xarxa Assistencial Universitària de Manresa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05877131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05877131, "Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05877131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*